Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Immunovant Q3 EPS $(0.36) Up From $(0.49) YoY, Cash And Cash Equivalents Totaled Approximately $691M

Author: Benzinga Newsdesk | February 12, 2024 08:11am
Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.36) per share. This is a 26.53 percent increase over losses of $(0.49) per share from the same period last year.

Posted In: IMVT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist